CSBR — Champions Oncology Balance Sheet
0.000.00%
- $66.67m
- $63.16m
- $59.43m
Annual balance sheet for Champions Oncology, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2022 April 30th | 2023 April 30th | 2024 April 30th | 2025 April 30th | 2026 April 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 9.01 | 10.1 | 2.62 | 9.79 | 4.87 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 9.51 | 8.01 | 9.53 | 11.2 | 13.2 |
| Prepaid Expenses | |||||
| Total Current Assets | 19.7 | 19.5 | 13.6 | 22.4 | 19.2 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 15.4 | 14.5 | 12 | 9.46 | 7.22 |
| Net Goodwill | |||||
| Other Long Term Assets | |||||
| Total Assets | 35.4 | 34.3 | 26.1 | 32.3 | 27 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 17.5 | 21.7 | 21.5 | 23.9 | 19.9 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 26.3 | 29.7 | 28 | 28.6 | 23.1 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 9.1 | 4.64 | -1.9 | 3.77 | 3.94 |
| Total Liabilities & Shareholders' Equity | 35.4 | 34.3 | 26.1 | 32.3 | 27 |
| Total Common Shares Outstanding |